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Introduction
The COVID-19 crisis has undoubtedly taken a toll on
the care of patients with colorectal disease. Elective ser-
vices, be that face-to-face contact, endoscopy or opera-
tions, all but ceased during the pandemic [1]. As we
move into the recovery phase the return to normal care
is likely to be slow, with a huge backlog of patients and
ongoing limitations to services. Some of the changes in
care and new ways of working enforced by COVID-19
will be permanent. However, this ‘legacy’ of COVID-
19 is not entirely negative. The pandemic has thrown
into sharp relief some of the poorly thought through
systems and practices that were in place previously and
forced change to certain areas of practice that have
proved beneficial. If we can identify, nurture and embed
these positive changes there is an opportunity to
improve patient care.
The psychology of a crisis is well defined. The initial
‘heroic’ phase is followed by a honeymoon phase, both
characterized by clear shared goals and a sense of
urgency that energizes the workforce to be focused and
productive. The disillusionment phase follows, in which
uncertainty about the future reduces any sense of pur-
pose, and productivity falls. Finally, there is the recon-
struction phase, in which we begin to revise our goals,
expectations and roles and to focus on moving beyond
‘just getting by’ [2–4].
This document aims to define the positive outcomes
from the crisis and to explore how the colorectal com-
munity can reframe its future direction. It is hoped this
will serve as a catalyst to move us swiftly and effectively
through to the reconstructive phase and guide priorities
accordingly (see Appendix S1).
The patient
Our overarching aim is to improve care for patients.
Any legacy from the COVID-19 crisis must clearly have
patients’ interests ‘front and centre’ with other factors
feeding into this central theme (Fig. 1). We have, at
best, only a notion of what patients really want from
their health service, and welcome initiatives such as the
recently described ‘citizen juries’ [5] to redress this
knowledge gap. Nevertheless, we can make some clear
suggestions, starting with the realization of the impor-
tance of high-value care during the crisis – in other
words, the opportunity to make the biggest differences
to patient care with the minimum resources available.
With reference to colorectal diseases, pre-COVID-19
systems were typically overburdened with huge numbers
of referrals of patients whose symptoms, whilst clearly
troublesome to them, were not eventually associated
with the finding of significant pathology. The ‘old’
paradigm involved invasive and expensive investigation
of such patients with a near exclusive focus on the
exclusion of cancer – to the extent that the primary rea-
son the patient attended in the first place, namely man-
agement of their problem, was often neglected or
forgotten. This is a grossly inefficient way of working; it
puts patients at unnecessary risk of investigation and has
little benefit for those who need treatment for condi-
tions other than bowel cancer. Attempts to rectify this
situation, pre-COVID-19, had been limited to small
changes such as modified referral criteria to try to con-
trol the influx of patients. We now have an opportunity
for major and meaningful change. Obvious examples
are modifications to the 2-week-wait and straight-to-test
pathways. Both are leading to an ever-increasing drain
on limited endoscopy resources, a decreasing efficacy in
identifying significant pathology as only cancer detec-
tion is prioritized and often inappropriate discharge of
patients symptomatic from other pathologies. Rapid
integration of proven adjunctive diagnostic tools such as
the faecal immunochemical test (FIT) in cancer detec-
tion pathways will allow more focused high-value care
[6].
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Coupled with this high-value care is the concept of
‘realistic’ and ‘personalized’ medicine approaches [7].
The clinician should refocus on shared decision-making
with the patient when planning investigations and treat-
ment. The risks and benefits of testing or treating
should be discussed in detail and the patient allowed to
decide what is best for them. This personalized
approach can deliver efficiencies that will keep the
healthcare system sustainable in the face of rising costs.
It requires honesty about expectations, including the
description of all alternative treatment options. Patients
may have accepted during the crisis that there was a vir-
tual shutdown of services, but lack of resources is not
new and even after the recovery is likely to be worse
than in the pre-COVID-19 era.
Given the universal backlog of patients awaiting
endoscopy and surgery in the recovery period, there is
an opportunity to apply the realistic medicine principle
to those who, for instance, have been waiting a long
time; they may not need or want the intervention
planned at all (e.g. those on polyp surveillance with
only a diminutive polyp burden). High-value care must
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Figure 1 Summary of the ’legacy’ of COVID19. ERAS, enhanced recovery after surgery; FIT, faecal immunochemical testing;
EGS, emergency general Surgery.
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be inclusive, applying to both suspected and proven
malignant diagnosis and to diseases that are less com-
mon. For instance, some patients with faecal inconti-
nence had been effectively self-isolating for years before
COVID-19 came along and are now at the back of an
even longer queue despite having a condition that radi-
cally reduces their quality of life.
Another issue highlighted during the crisis was the
obvious motivation for patients undergoing elective sur-
gery to leave hospital rapidly. Experience from Lom-
bardy suggests the median length of postoperative stay
was reduced by over 1 day, despite a pre-COVID-19
enhanced recovery policy, with no obvious adverse
sequelae [8]. Their experience implies we can push the
enhanced recovery process even further provided patient
motivation can be instilled and there is adequate safety
netting.
The health system
Reconfiguration of services
Over many years, and with the best of intentions, sev-
eral initiatives have been introduced to streamline
patient care. Many were scientifically based but political
influence and greater patient expectations have not been
matched by a resource-constrained National Health Ser-
vice (NHS). The consequence was overwhelmed services
and significantly reduced efficiency. There may be an
opportunity to reset and reconfigure some services.
The 2-week-wait referral pathway for suspected col-
orectal cancer has already been mentioned. Of all
patients investigated on the colorectal cancer pathway,
only 3% have bowel cancer [9] and the majority of
patients with bowel cancer are still diagnosed outside of
the 2-week-wait investigation pathway. Add to that the
fact that referrals for colonoscopy due to symptoms
exceed those through bowel cancer screening by a fac-
tor of 7:1 and it is no wonder the colonoscopy services
are overwhelmed [9]. Solutions include diagnostic inno-
vations such as the FIT already implemented in the
symptomatic referral pathway in Scotland, but also
other novel diagnostic tools such as the colon capsule
[10].
Working closely with primary care allows the effec-
tive delivery of alternative cancer detection pathways.
There may be additional ways in which assessment and
rationalization of investigations can occur in primary
care and reduce some urgent referrals that place pres-
sure on secondary care with little tangible patient bene-
fit. For instance, frailty scoring in the primary setting
could identify patients who are never going to be fit
enough to benefit from surgery and who would be
better served with palliative input or a more routine
surgical opinion. The most frail, for whom surgery is
unlikely to be an option, may benefit from a virtual
appraisal by the hospital colorectal team, possibly avoid-
ing the need for hospital attendance. If investigation is
deemed appropriate, it may be tailored to the individ-
ual. CT abdomen/pelvis protocols including faecal tag-
ging alone (minimal preparation CT) in much older
and frail individuals, in whom the primary aim is to
exclude major pathology, may be more appropriate than
subjecting them to full oral bowel preparation [11]
whilst remaining mindful of not overburdening radiol-
ogy services.
A considerable amount of resource goes into bring-
ing frail, elderly patients to hospital for appointments.
Political pressures allied with medicolegal concerns have
undoubtedly resulted in a more defensive attitude in
medicine. There is fear across both primary and sec-
ondary care of missing a cancer diagnosis. These
approaches will reassure primary-care clinicians and
reduce the need for hospital resources and the carbon
footprint of the NHS. This footprint could be further
reduced by the use of virtual clinics for all age groups as
it is increasingly apparent that much of secondary care
can be delivered without hospital attendance. Perma-
nent integration of virtual clinics to reduce inconve-
nience to the patient is an essential component of
future patient-centred care [12].
Ready access for general practitioners to specialist
advice will further aid stratification of patients at pri-
mary-care level. Front-of-door services such as consul-
tant-led ‘hot’ clinics and telephone advice results in
reduced hospital foot fall and more rapid discharge.
Integration of services
Integration is a sensitive subject, particularly when it is
taken to mean centralization of services. COVID-19 has
brought a sharp focus on preexisting inequalities in
quality of healthcare provision as some regions have
been able to continue essential elective colorectal ser-
vices, primarily due to integrated service provision [13].
In view of this, there is now more than ever a com-
pelling argument to move beyond considering hospital
walls as a boundary to clinical care and investigating
models that view a waiting list by regional population,
rather than hospital, to improve outcomes. In many
respects, the UK has led the way with national patient
registries and publication of colorectal cancer outcomes
in the public domain (e.g. National Bowel Cancer
Audit), multidisciplinary teams, training (total mesorec-
tal excision, Laparoscopic Colorectal Surgery Pro-
gramme, Low Rectal Cancer Programme) as well as
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data on screening. Both the Republic of Ireland and
Denmark have copied these initiatives and further built
on them by reducing the number of centres treating
rectal cancer [14,15]. Similarly, surgery for advanced
pelvic malignancy is carried out in even fewer Danish
centres and only five centres perform elective surgery
for patients with parastomal hernias in a country of a
similar population and size to Scotland. The UK still
ranked bottom for colorectal cancer survival in a league
table of seven high-income countries in 2019 [16] and
compares poorly in terms of commitment to improving
outcomes by centralizing expertise. For instance, almost
all UK acute hospitals offer rectal cancer surgery but
only 85 institutions in England and Wales carry out
more than 25 elective rectal cancer resections each year,
and just 34 have a caseload greater than 40 per year;
too many also claim to carry out pelvic exenteration
[17]. The data for ileoanal pouch surgery are even more
stark; recent data suggest that in more than 80% of
NHS Trusts less than one pouch procedure is per-
formed each year [18]. The data-driven, evidence-based
approach to rationalizing services to achieve high-qual-
ity care in Denmark has highlighted the lack of progress
in the UK over the same time frame.
Barriers to integration are complex and multifacto-
rial. Some fault inevitably lies with the vested interests
of healthcare professionals and managers, but political
forces also exist where hospital services in any particular
constituency are considered to be under threat. The
COVID-19 crisis has in some regions, particularly Lon-
don, removed some of these barriers, allowing a smarter
and more rational use of constrained resources. The
likely differing speed of recovery in different hospitals
strengthens regional solutions to waiting times. Patients
appear to be willing to travel to get better care [19].
The possibility of being able to deliver high-value care
by a system that integrates care across hospitals is there-
fore appealing provided there is fair collaboration of
hospital managers and healthcare boards. This may be
aided further by the digital revolution that has occurred
during the pandemic, allowing easier communication
between specialists in different hospitals (see below).
There are strong caveats to promoting such a
change. It is easy to criticize conflation with COVID-
19 and that such integration is the wish of self-serving
opportunists. However, resistance to change may be
perceived as protectionist, reactionary and blind to qual-
ity outcomes for patients.
A final point is that integration of services into regio-
nal pathways offers an opportunity to provide some
redress for patient groups that, pre-COVID-19, have
been commonly disenfranchised from hospital care,
either in terms of access to, or wait for, specialist
treatment. Patients with faecal incontinence, other pel-
vic problems such as rectal prolapse, temporary stomas
and stoma problems have already received a raw deal
from the NHS in terms of long waiting times. Most will
not be excited about returning to a ‘normal’ that treats
them as a ‘less profitable’ inconvenience in comparison
to mainstream disease pathways such as cancer. A sepa-
rate initiative led by the UK Pelvic Floor Society is
developing a report with particular focus on these
issues, but the remarks above apply to many bowel dis-
eases that are chronic and difficult to cure.
Emergency surgery
During the COVID-19 pandemic, the number of
patients attending emergency departments or seeking
help from primary care fell dramatically. Within the sur-
gical community there were widespread concerns about
the risks of emergency surgery, based mainly on the
Chinese and Italian experiences [20,21].
A key theme of the advice issued by Public Health
England, Joint Royal Colleges and Specialty Associa-
tions was to avoid unnecessary surgery due to the
unknown (at that time) risks of COVID-19. Conserva-
tive management of emergency conditions was advised
whenever possible, with increasing use of radiological
drainage and antibiotics. As we return to more standard
management algorithms, the effect of this change on
management of conditions such as appendicitis, chole-
cystitis and diverticulitis is being assessed in a series of
national research projects. Initial results suggest it may
be safe to continue this more conservative approach in
selected individuals [22] thereby potentially reducing
patient harm and use of hospital resources.
The workforce
Culture
The culture of the workforce has in many respects changed
beyond recognition. In some hospitals, the temporary
freedom from bureaucratic norms led to tremendous
advances in a short period of time. Examples included
rapid procurement, implementation of modern IT hard-
ware and even relocation of whole departments overnight.
Remote working was possible and the ‘PA counting’ atti-
tude was temporarily dropped. COVID-19 highlighted
what good teamwork between management and clinical
staff can achieve. Progress was built on respect, trust and
overall professionalism. Both parties should reflect on this
nonadversarial approach, as it was clearly productive. We
need to avoid a return to a normal characterized by
bureaucratic hurdles and glacial slowness; rather, mutual
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trust should continue so that both managers and clinicians
can push things forwards. There is also need for honesty in
speaking out where clinicians are unable to deliver existing
standards of care (e.g. National Institute of Health and
Care Excellence) due to resource constraints without fear
of persecution for failing to deliver preexisting standards in
a constrained environment over which they had no profes-
sional control.
The positive cultural changes between clinicians and
management have not been universal. In some hospi-
tals, inadequacies have been magnified by COVID-19
with an increase in bureaucracy and paralysis of services
due to both clinical and nonclinical management
incompetence. There have been instances of surgeons
being bullied regarding PPE and perceived risk. The
surgical leadership shown by the Royal Colleges work-
ing with the speciality societies including the Associa-
tion of Surgeons of Great Britain and Ireland, the
Association of Coloproctology of Great Britain and Ire-
land (ACPGBI) and the Association of Upper Gastroin-
testinal Surgery of Great Britain and Ireland has been
impressive in providing a joint voice for clinicians to
stand behind in this respect, and future close collabora-
tion should persist [23].
Working as a team
The COVID-19 crisis has highlighted the tangible bene-
fits of working in a close surgical team, particularly when
providing continuity of care. Communication has been
enhanced with more efficient handovers utilizing the
resources available within each department. Engagement
has happened with all tiers of doctors within the surgical
department and has redefined referral pathways with
other hospital specialities, moving away from consultant
to consultant conversations and empowering all surgical
team members to have different and flexible roles.
Although this structure has allowed for much needed
moral support, the mental strain on surgeons should
not be underestimated. Our leadership traits of organi-
zation, emotional stability and a capacity to think fast
should naturally place us in a position to respond posi-
tively to a pandemic [24]. However, rapid and sustained
overload as occurs in a pandemic can lead to burnout,
especially if patient outcomes are poor and there has
been an experience of loss of control [24]. Whilst we
rely on colleagues, family and friends to support us dur-
ing these times, professional bodies need to consider
embedding wellness and mental health into their per-
sonnel strategies with immediate effect as the conse-
quences from this pandemic may only just be
beginning. This moral injury has still to fully play out
and may cause another challenging ‘wave’ in healthcare.
In many hospitals, restoration of a structure resem-
bling the old ‘surgical firm’ has been possible with a
consultant-led service allowing proper and timely deci-
sions to occur with continuity of care paramount. The
concern about such a model is its sustainability and this
includes the flattening of hierarchy, which has good and
bad points. In the past firms required long hours to
generate continuity. In the current model of consul-
tant-led practice with consultant expansion this may not
be sustainable in the long term. One option is to con-
sider job planning flexibility, which for many of us hap-
pened naturally during this pandemic. Whilst by no
means supporting any form of consultant hierarchy, one
example of flexibility could be using the experience of
the older consultant more wisely and acknowledging
that role. Older consultants are more likely to have
refined decision-making skills and wisdom to impart to
newly appointed colleagues that can facilitate efficient
patient care and optimize outcomes. There is a danger
that many older consultants move to the psychological
disillusionment phase and elect to retire [2]. If not
countered this may have dire consequences for the
expected workforce gap that is expected in the near
future [25]. Ideally a department should use its consul-
tant body to best effect as younger consultants may
bring new ideas and innovation in service provision to
benefit patients in other ways. Lifelong learning is very
much a part of the career surgeon’s make-up. We
believe that job planning reviews should be significantly
restructured to allow flexibility according not only to
departmental needs but also to the needs of the individ-
ual surgeon at that time. Careers should be considered
like chapters in a book. Discussions should include flexi-
ble working hours, part-time working, sabbaticals with
a culture change that embraces this, rather than the
view that long difficult hours is ‘just something to get
through’ because ‘we have all done it’. Implementation
and demonstration of such a culture change may
encourage more medical students to become surgeons
and help address the urgent decline in the numbers
applying for surgical training.
The importance of stable colorectal nursing teams
both on the ward and in theatre has been critical. Our
nursing colleagues took great pride in working more
closely with us and we with them; this should not be
forgotten. The World Health Organization theatre
checklist came into its own more than ever before as a
means of focusing on the challenges of delivering surgi-
cal care in a constrained theatre environment and with a
theatre team drawn from multiple backgrounds. In
addition, expansion of the nondoctor, nonconsultant
workforce is key, allowing colleagues to practise to the
limit of their licence. This could be called the ‘Special
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Air Services approach’; it does not matter what your cap
badge or rank, if you are an expert at delivery you can
do the job.
Health Education England (HEE) has worked with
the Royal College of Surgeons of England to develop a
programme to improve surgical training (IST) within
the context of the Shape of Training [26]. Concurrently
the Royal College of Surgeons of England articulated
the importance of the extended surgical team (EST)
[27]. Given the experience of both IST and EST over
the last 5 years the time is right to recognize their
inter-dependence. It is hoped that a combined approach
will meet trainees’ needs, increase time for training and
support the development of the multi-professional
workforce. The aim of these changes is to improve sur-
gical care for patients. The COVID-19 pandemic has
illustrated the need for a broad-based clinical team with
more general clinical skills. Redeployment of surgical
staff to support critical care was best facilitated in cen-
tres able to provide team members from medical and
nonmedical backgrounds. Continuing to enhance the
skill mix of the surgical workforce by replicating this
model with new roles and advanced clinical practitioners
will require financial support but ultimately will benefit
surgical trainees and patients. Plans by HEE to formal-
ize this initiative are currently in discussion.
Training
The crisis had, and continues to have, a huge impact on
trainees. There have been no examinations or face-to-
face educational conferences. Dual consultant operating
led to lack of operating experience. Many trainees lost
access to training due to relocation of elective major
cancer surgery to the independent sector, though this
issue is currently being addressed at national level.
Endoscopy training completely disappeared and is only
just returning for the most senior trainees closest to
Joint Advisory Group accreditation. On top of this
there are new curriculum changes planned, although
implementation of the new curriculum has been sensibly
deferred to August 2021.
Training and training systems need to be revised to
reflect the needs and skills of its end-users – surgical
trainees. Modern-day trainees are innovative, versatile
and digitally enabled and need a training system which
reflects this. Apprenticeship-based training alone is an
outdated modality of training. There needs to be a
movement towards delivering the key building blocks of
training across a range of trainers and hospitals using a
combination of training methods, including simulation,
virtual reality, robotics, telemedicine and gaming. Train-
ing programmes need to be meritocratic to enable
trainees to thrive and guide their own career pathways,
whilst ensuring that the wider needs of the health ser-
vice are appropriately met. This is essential towards
developing a future dynamic workforce with a broad-
ranging skills set.
We should recognize and applaud the flexibility and
adaptability demonstrated by our trainees during the
pandemic. Consultants and trainees alike have gained
many nontechnical skills including stress management,
support structures and team work.
Innovation
The digital revolution
The COVID-19 pandemic has acted as a catalyst for the
advancement of telemedicine and digital healthcare. In
just a few months there has been widespread lightning-
fast adoption of virtual consultations, meetings and con-
ferencing platforms. The way we now conduct the
everyday business of healthcare in terms of meetings for
any purpose has changed for the better. Face-to-face
meetings could now be reserved for difficult decision-
making only when there is a defined and explicit pur-
pose for that approach. We envisage much more effi-
cient use of time as we remove the need for unnecessary
travel to attend committee, management, research and
educational meetings that were traditionally face-to-face.
The etiquette of well-chaired videoconference meetings
may lead to them becoming of much greater value than
before due to quieter voices having a much greater
chance to be heard, especially if attention is paid not
just to what is said but what is communicated to the
meeting via ‘chat’ functions [28]. Conferences will now
have wider reach for those not able to travel or attend
an entire educational event, as recently demonstrated by
the entirely virtual ACPGBI 2020 annual conference.
Conferences may now be attended live but catch-up
on-demand is also readily available. This may help with
the fact that postgraduate educational budgets are virtu-
ally nonexistent. Nevertheless, the power of peer sup-
port and professional interaction will still mandate need
for face-to-face conferences but there will be greater
freedom and choice in both participation and atten-
dance. Societies who base a significant proportion of
their income on revenue from annual events may have
to rethink their financial model.
The advent of this new era of digital technology will
perhaps deliver the greatest difference for the patient–
surgeon interaction. Clearly, there are patients who
need to be seen in person: symptoms and signs to be
diagnosed, difficult decisions to be made with patients
and their families and some who will not be able to
ª 2020 The Authors. Colorectal Disease published by John Wiley & Sons Ltd on behalf of Association of Coloproctology of Great Britain and Ireland.6
Legacy of COVID-19 ACPGBI Legacy Working Group
embrace the technology. However, getting to the hos-
pital, finding somewhere to park, locating the clinic and
waiting to be seen often involves a half day out for
many patients. When this level of effort is just for a
10 min follow-up consultation or explanation of normal
results it is impossible to justify during a time when we
are trying to reduce footfall in our healthcare institu-
tions and deliver sustainable healthcare. Initial concerns
that the elderly will be disadvantaged by not being able
to use the technology have been unfounded as baby
boomers became ‘baby zoomers’ during lockdown to
keep in touch with friends, children and precious grand-
children. The expansion of technologies into preassess-
ment, prehabilitation and rehabilitation indicates than
the time has come for a sea change in the way we deli-
ver perioperative healthcare services.
However, it is noted with regret that the implemen-
tation of digital technology has been difficult in some
hospitals. The existing IT infrastructure has been simply
inadequate, reflecting years of under-funding. Comput-
ers without a camera, out of date browsers, firewall
blocks on downloading software and updates and long
waits for IT services have been common experiences.
Given the clear advantages of digital medicine, it is
essential to remedy these deficiencies as a top priority.
Without investment in connectivity the digital revolu-
tion will grind to a halt.
There is also a potential minefield of data protec-
tion and legal issues to consider. The General Medical
Council (GMC) published a report entitled ‘Regula-
tory approaches to telemedicine’ in January 2018
[29]. The executive summary noted that the require-
ments applicable to the provision of telemedicine usu-
ally include ensuring the same standard of care as
that of face-to-face healthcare, obtaining patient con-
sent for telemedicine in provision of medical services
and confirming patient identity. Nevertheless, it is
clear that telemedicine brings so much potential to
the future of surgical care that it is imperative not to
miss the opportunity to embrace and implement it
into everyday practice.
Research
Clinical and translational research forms the cornerstone
of the surgical knowledge base and is fundamental to
improving patient outcomes. Traditional research
methodology provides rigour but the recent crisis has
highlighted the limitations of evidence-based medicine.
During the crisis, evidence was lacking in almost every
important decision faced by surgeons and healthcare
leaders. Researchers, clinicians and journals have worked
to accelerate the pace of progress, driving our
traditional research models more rapidly to provide an
early evidence base on which to base clinical recommen-
dations. This accelerated process has resulted in an evi-
dence base of variable quality, both high and low, with
some lamentable missteps that were fortunately quickly
and publicly acknowledged by both authors and jour-
nals [30]. Despite the obvious challenges, a positive
impact of the COVID-19 pandemic has been the
removal of some barriers to research, resulting in a
more dynamic research environment characterized by a
more streamlined ethical approval framework and
greater collaboration. A healthcare system that values
learning from research endeavour must retain and
embrace swift mechanisms to foster and champion a
research climate that allows researchers to move at pace
through traditional administrative research funding and
ethical approval bureaucracy. Many researchers have jus-
tifiably used the unusual opportunity of the natural
experiment provided by COVID-19 to pursue large-
scale observational research on recommended changes
from standard practice through prospective cohort study
designs. Although cohort studies are considered inter-
nationally to be low risk, they still typically require
extensive paperwork and interminable delays for
approval in current systems but this has been rapidly
overcome in adversity, and should not revert to ‘stan-
dard practice’ hereafter. Several colorectal researchers
have made observations on the utility of various alterna-
tive treatment strategies (or absence of usual treat-
ments) in a timescale that would be unimaginable
before COVID-19, and we should seek to continue this
legacy of rapid implementation of necessary research
studies.
Randomized controlled trials retain an important
role in advancing knowledge of best practice but sur-
geons must also embrace and adapt rapid cycle method-
ologies to increase our capacity to learn collectively
from rapidly changing circumstances in varying real-
world scenarios [31]. COVID-19 has precipitated a
renewed appreciation of research activity with engage-
ment from clinicians not ordinarily involved in clinical
research. It is imperative to utilize the opportunity to
expand the large body of research-active surgeons who
collaborate to set priorities and develop test sites for
evidence-based change in the way we practice. While
this body of work remains largely invisible in the surgi-
cal literature, surgical journals and editorial boards have
an important role in developing a new research culture
that recognizes the work of surgeons who lead change.
Research that ensures that surgical practice over the
coming decade is as safe as possible and that focuses on
outcomes that matter to patients must be supported
[32].
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Concluding remarks
The expression ‘never let a good crisis go to waste’ is
apposite for our time. There was a crisis and we as a
community of colorectal surgeons weathered the storm,
were pushed to the front and got on with it. The
majority stepped up and were creative and responsive.
This was particularly the case when not managed by ses-
sional working, just by getting the job done profession-
ally and doing the right thing. There was fulfilment of
working in a cohesive team. Despite the dangers
involved, many colorectal surgeons, trainees and nurses
have thrived in the atmosphere of just being allowed to
work in a professional manner.
The inadequacies of many aspects of the current
healthcare system are now exposed, papering over the
cracks will no longer be acceptable, and the need for
fundamental change to provide a patient-centred
approach should now be realized with reorganization
and integration of services. Innovation has enabled
aspects of care to be delivered more conveniently for
patients and should be embedded in our vision for
future colorectal care. Training has suffered, but oppor-
tunities abound to change the ethos and context of
training to suit the demands of modern trainees and
their trainers.
In colorectal surgery we are not alone as a speciality
in recognizing that healthcare workers have suffered
during COVID-19. While it is acknowledged that the
positives highlighted here are far from ubiquitous, we
hope that we may collectively learn from and implement
some of the amazing opportunities that have been pre-
sented. If we translate these views into improvements in
delivering patient-centred realistic personalized care,
research, professionalism and sustainable practices we
set an impressive blueprint for delivering a future of
enhanced healthcare in colorectal surgery.
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